Company

Vaxart, Inc.

Biotechnology Research South San Francisco, California, United States 122 employees

Employees: 122
Contacts: 4
Emails: 4
Phones: 1

vaxart.com LinkedIn Crunchbase

Vaxart, Inc. Overview

Headquarters: South San Francisco, California, United States
Website: vaxart.com
Industry: Biotechnology Research
Employees: 122
Founded: 2004
Funding: 40.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Biotechnology and Vaccines

About Vaxart, Inc.

For two hundred years vaccines have been administered by intramuscular injection. Vaxart’s oral vaccine pills may change everything. Our vaccine pills act differently, by attacking invading pathogens in the places where they first enter the body: the mucosal areas, including the mouth, the nose and the gut. They are designed to trigger strong IgA and T-cell responses to repel and overwhelm the invading viral invaders. Vaxart has begun Phase II trials of its oral vaccine for Covid and for Norovirus– the only company in the world to reach this stage with a COVID-19 vaccine pill.

Vaxart, Inc. Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 1; 25.0% coverage

Vaxart, Inc. Org Chart

Sample employees and titles

Name	Title	Location	Contact
Emery Dora	Corporate Development at Vaxart Inc.	San Francisco Bay Area, United States	Email
Malik Rafi		Los Angeles Metropolitan Area, United States	Email Phone
Pam De Moor	Vice President, Formulations at Vaxart	Palo Alto, California, United States	Email
Vu Tran		San Jose, California, United States	Email